Colorectal cancer-targeted delivery of oxaliplatin via folic acid-grafted solid lipid nanoparticles: preparation, optimization, and in vitro evaluation

References

• Schwarz C, Mehnert W, Lucks JS, et al. Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization. J Control Release. 1994;30:83–96.
   Web of Science ®Google Scholar
• Taylor MS, Daniels AU, Andriano KP, et al. Six bioabsorbable polymers: in vitro acute toxicity of accumulated degradation products. J Appl Biomater. 1994;5:151–157.
   PubMedGoogle Scholar
• Jenning V, Gohla SH. Encapsulation of retinoids in solid lipid nanoparticles (SLN). J Microencapsul. 2001;18:149–158.
   PubMed Web of Science ®Google Scholar
• Pooja D, Kulhari H, Kuncha M, et al. Improving efficacy, oral bioavailability, and delivery of paclitaxel using protein-grafted solid lipid nanoparticles. Mol Pharm. 2016;13:3903–3912.
   PubMed Web of Science ®Google Scholar
• Wang F, Li L, Liu B, et al. Hyaluronic acid decorated pluronic P85 solid lipid nanoparticles as a potential carrier to overcome multidrug resistance in cervical and breast cancer. Biomed Pharmacother. 2016;86:595–604.
   PubMed Web of Science ®Google Scholar
• Soni N, Soni N, Pandey H, et al. Augmented delivery of gemcitabine in lung cancer cells exploring mannose anchored solid lipid nanoparticles. J Colloid Interface Sci. 2016;481:107–116.
   PubMed Web of Science ®Google Scholar
• Yuan F, Dellian M, Fukumura D, et al. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res. 1995;55:3752–3756.
   PubMed Web of Science ®Google Scholar
• Yang SJ, Lin FH, Tsai KC, et al. Folic acid-conjugated chitosan nanoparticles enhanced protoporphyrin IX accumulation in colorectal cancer cells. Bioconjug Chem. 2010;21:679–689.
   PubMed Web of Science ®Google Scholar
• Ji J, Zuo P, Wang YL. Enhanced antiproliferative effect of carboplatin in cervical cancer cells utilizing folate-grafted polymeric nanoparticles. Nanoscale Res Lett. 2015;10:453.
   PubMed Web of Science ®Google Scholar
• Kennedy MD, Jallad KN, Lu J, et al. Evaluation of folate conjugate uptake and transport by the choroid plexus of mice. Pharm Res. 2003;20:714–719.
   PubMed Web of Science ®Google Scholar
• Graham J, Muhsin M, Kirkpatrick P. Oxaliplatin. Nat Rev Drug Discov. 2004;3:11–12.
   PubMed Web of Science ®Google Scholar
• Culy CR, Clemett D, Wiseman LR. Oxaliplatin. A review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignancies. Drugs. 2000;60:895–924.
   PubMed Web of Science ®Google Scholar
• Jain A, Jain SK, Ganesh N, et al. Design and development of ligand-appended polysaccharidic nanoparticles for the delivery of oxaliplatin in colorectal cancer. Nanomedicine. 2010;6:179–190.
   PubMed Web of Science ®Google Scholar
• Cho HJ, Park JW, Yoon IS, et al. Surface-modified solid lipid nanoparticles for oral delivery of docetaxel: enhanced intestinal absorption and lymphatic uptake. Int J Nanomedicine. 2014;9:495–504.
   PubMed Web of Science ®Google Scholar
• Raj R, Raj PM, Ram A. Preparation and characterization of solid lipid nanoparticles loaded with cytarabine via a micellar composition for leukemia. RSC Adv. 2016;6:53578–53586.
   Web of Science ®Google Scholar
• Hu FQ, Yuan H, Zhang HH, et al. Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in aqueous system and physicochemical characterization. Int J Pharm. 2002;239:121–128.
   PubMed Web of Science ®Google Scholar
• Gupta Y, Jain A, Jain SK. Transferrin-conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain. J Pharm Pharmacol. 2007;59:935–940.
   PubMed Web of Science ®Google Scholar
• Fry DW, White JC, Goldman ID. Rapid separation of low molecular weight solutes from liposomes without dilution. Anal Biochem. 1978;90:809–815.
   PubMed Web of Science ®Google Scholar
• Cavaco MC, Pereira C, Kreutzer B, et al. Evading P-glycoprotein mediated-efflux chemoresistance using Solid Lipid Nanoparticles. Eur J Pharm Biopharm. 2017;110:76–84.
   PubMed Web of Science ®Google Scholar
• Mehnert W, Mäder K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Del Rev. 2001;47:165–196.
   PubMed Web of Science ®Google Scholar
• Luo Y, Teng Z, Li Y, et al. Solid lipid nanoparticles for oral drug delivery: chitosan coating improves stability, controlled delivery, mucoadhesion and cellular uptake. Carbohydr Polym. 2015;122:221–229.
   PubMed Web of Science ®Google Scholar
• Taveira SF, De Santana DC, Araujo LM, et al. Effect of iontophoresis on topical delivery of doxorubicin-loaded solid lipid nanoparticles. J Biomed Nanotechnol. 2014;10:1382–1390.
   PubMed Web of Science ®Google Scholar
• Martins SM, Sarmento B, Nunes C, et al. Brain targeting effect of camptothecin-loaded solid lipid nanoparticles in rat after intravenous administration. Eur J Pharm Biopharm. 2013;85:488–502.
   PubMed Web of Science ®Google Scholar
• Alex MRA, Chacko AJ, Jose S, et al. Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting. Eur J Pharm Sci. 2011;42:11–18.
   PubMed Web of Science ®Google Scholar
• Chalikwar SS, Belgamwar VS, Talele VR, et al. Formulation and evaluation of Nimodipine-loaded solid lipid nanoparticles delivered via lymphatic transport system. Colloids Surf B Biointerfaces. 2012;97:109–116.
   PubMed Web of Science ®Google Scholar
• Müller RH, Mäder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art. Eur J Pharm Biopharm. 2000;50:161–177.
   PubMed Web of Science ®Google Scholar
• Morel S, Terreno E, Ugazio E, et al. NMR relaxometric investigations of solid lipid nanoparticles (SLN) containing gadolinium(III) complexes. Eur J Pharm Biopharm. 1998;45:157–163.
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Ray S, Thakur RS. Solid lipid nanoparticles: a modern formulation approach in drug delivery system. Indian J Pharm Sci. 2009;71:349–358.
   PubMed Web of Science ®Google Scholar
• Bunjes H, Steiniger F, Richter W. Visualizing the structure of triglyceride nanoparticles in different crystal modifications. Langmuir. 2007;23:4005–4011.
   PubMed Web of Science ®Google Scholar
• Bunjes H, Westesen K, Koch MHJ. Crystallization tendency and polymorphic transitions in triglyceride nanoparticles. Int J Pharm. 1996;129:159–173.
   Web of Science ®Google Scholar
• Bishnoi M, Jain A, Hurkat P, et al. Aceclofenac-loaded chondroitin sulfate conjugated SLNs for effective management of osteoarthritis. J Drug Target. 2014;22:805–812.
   PubMed Web of Science ®Google Scholar
• Kharya P, Jain A, Gulbake A, et al. Phenylalanine-coupled solid lipid nanoparticles for brain tumor targeting. J Nanopart Res. 2013;15:2022.
   Web of Science ®Google Scholar
• Jain A, Kesharwani P, Garg NK, et al. Galactose engineered solid lipid nanoparticles for targeted delivery of doxorubicin. Colloids Surf B Biointerfaces. 2015;134:47–58.
   PubMed Web of Science ®Google Scholar
• Kim H, Jo A, Baek S, et al. Synergistically enhanced selective intracellular uptake of anticancer drug carrier comprising folic acid-conjugated hydrogels containing magnetite nanoparticles. Sci Rep. 2017;7:41090.
   PubMed Web of Science ®Google Scholar